What Mercury Laboratories does

Mercury Laboratories Limited (BSE: MERCURYLAB) is a publicly listed Indian pharmaceutical manufacturer founded in 1960, specializing in Mother & Child Healthcare formulations. The company operates a 435,600 sq. ft. manufacturing facility in Vadodara, Gujarat, producing multiple dosage forms including tablets, oral liquids, small volume parenterals, and ophthalmic preparations, with a registered office in Mumbai. Its product portfolio comprises 14 top-branded specialty drugs organized into four therapeutic business units: Gynecology (antihypertensives for pregnancy-induced hypertension, galactagogues, PCOS treatments, uterotonics, antifungals, and haemostats), Pediatrics (digestive enzymes, laxatives, vitamin D, and nutritional supplements), Surgery (haemostatic agents), and General Practice (broad-spectrum formulations).

The company generates revenue through one-time sales of branded pharmaceutical formulations across domestic Indian and international export markets. Domestically, Mercury Labs operates a field sales force targeting OB-GYNs, pediatricians, surgeons, and general physicians across India. Internationally, it maintains direct presence in 25+ countries and indirect channels in 15+ additional markets across Southeast Asia, Africa, Latin America, the UK, USA, Moldova, and Jamaica. International market access is supported by country-specific regulatory registrations including NAFDAC (Nigeria), FDA (Ghana), DPML (Ivory Coast), MoH (D.R. Congo), CDDA (Sri Lanka), and MoH (Cambodia), in addition to ISO 9001 and ISO 14001 quality certifications. Pricing is quote-based and not publicly disclosed, consistent with a B2B pharmaceutical distribution model.

Name

Mercury Laboratories

Legal name

Mercury Laboratories Ltd.

Website

https://mercurylabs.com

Company type

Public

Founded year

1960

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Mercury Laboratories is a publicly listed Indian pharmaceutical manufacturer founded in 1960, specializing in Mother & Child Healthcare formulations across gynecology and pediatrics, with a 435,600 sq. ft. Vadodara facility and export presence in 25+ countries.

Ownership category

akta.pro rank

Product category

Pharmaceutical Manufacturing

NAICS

Pharmaceutical and Medicine Manufacturing (32541)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Pharmaceutical formulations
• Generic drug manufacturing
• Mother child healthcare
• Tablet and capsule production
• Pharmaceutical export

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Pharmaceutical Product Sales: Manufacturing and marketing of pharmaceutical formulations including branded drugs for domestic Indian market and export markets

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Mercury Laboratories develops, manufactures, and distributes branded pharmaceutical formulations including tablets, oral liquids, small volume parenterals, and eye/ear drops. Its portfolio of 14 top brands covers gynecological, pediatric, surgical, and general practice therapeutic areas, with primary specialization in Mother & Child Healthcare. Products are sold in the domestic Indian market through a field sales force and exported to 25+ countries.

Product overview

Mercury Laboratories is a pharmaceutical manufacturer primarily dedicated to Mother & Child Healthcare, operating for over six decades. The company offers a portfolio of 14 top branded products organized across domestic and export market categories. The domestic portfolio spans four therapeutic segments: Gynecological (antihypertensives, galactagogues, PCOS treatments, uterotonics, antifungals, haemostats, nutritional supplements), Paediatric (digestive enzymes, constipation relief, vitamin D, anti-diarrhoeals), Surgeon (haemostats, vitamin K deficiency bleeding), and Physician (digestive enzymes, antifungals, constipation, vitamins). Export products cover 13 formulation categories including antibiotics, antimalarials, multivitamins, CNS, and cardiovascular formulations. The company operates a 435,600 sq. ft. manufacturing facility producing tablets, oral liquids, small volume parenterals, and ophthalmic preparations. International accreditations include registrations with NAFDAC Nigeria, FDA Ghana, DPML Ivory Coast, MoH R D Congo, CDDA Sri Lanka, and MoH Cambodia.

Differentiator

Problem solved

Functional benefit

Brands

• Gravidol: Used to treat high blood pressure and pregnancy-induced hypertension (PIH), including preeclampsia and eclampsia. Contains Labetalol Hydrochloride. Available in tablet and IV injection forms.
• Promolact
• Ovaryl
• T-Stat
• K-Stat
• C-Tocin
• Fenticap
• Doxilar-OD
• Pregnafol-DHA
• Merizyme
• Ezepeg
• K-Win
• UV-3
• Zidust

Products and services

• Gravidol

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Six partnerships are on record, tiered core.

• NAFDAC NigeriacoreOthersNational Agency for Food and Drug Administration and Control - regulatory body that has granted product registration approval to Mercury Labs for pharmaceutical market access in Nigeria
• FDA GhanacoreOthersFood and Drugs Authority of Ghana - regulatory body that has certified Mercury Labs products for market distribution in Ghana
• DPML Ivory CoastcoreOthersDirection de la Pharmacie, du Médicament et des Laboratoires - regulatory authority that has approved Mercury Labs pharmaceutical products for Ivory Coast market
• MoH R D CongocoreOthersMinistry of Health of Democratic Republic of Congo - government body that has registered Mercury Labs products for distribution in D.R. Congo
• CDDA Sri LankacoreOthersCosmetics, Devices and Drugs Authority of Sri Lanka - regulatory body that has certified Mercury Labs pharmaceutical formulations for Sri Lankan market
• MoH CambodiacoreOthersMinistry of Health Cambodia - regulatory body that has granted product registration to Mercury Labs for pharmaceutical distribution in Cambodia

Scale indicators3 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Mankind Pharma: Leading Indian pharma company with strong focus on women's health, gynecology, primary care and pediatric formulations, serving both domestic and emerging markets — closely mirrors Mercury Labs' therapeutic focus and GTM model.
• FDC Limited: Smaller Indian pharma focused on formulations in ophthalmology, anti-infectives and women's health with a domestic-plus-export model — comparable in scale, niche therapeutic focus and multi-dosage-form manufacturing to Mercury Labs.
• Torrent Pharmaceuticals: Indian mid-cap pharma with branded generics in gynecology, cardiology and CNS, with a meaningful emerging-markets export business — comparable therapeutic segmentation and international footprint to Mercury Labs.
• Alkem Laboratories: Indian pharma company with branded generics across anti-infectives, gynecology and primary care, exporting to emerging markets — closely comparable in therapeutic breadth and international footprint to Mercury Labs.
• Emcure Pharmaceuticals: Indian pharma manufacturer producing formulations in women's health, gynecology and primary care with growing international presence — comparable to Mercury Labs in product mix, dosage-form capability and emerging-markets focus.
• Zydus Lifesciences: Indian pharma manufacturer with branded formulations across women's health, cardiovascular and primary care, plus a strong emerging-markets export franchise — comparable in scale, product mix and export orientation to Mercury Labs.
• Indoco Remedies: Mid-sized Indian formulations manufacturer focused on domestic primary care, gynecology and pediatrics with select international markets — comparable scale, niche therapeutic mix and India-centric manufacturing base to Mercury Labs.
• Ajanta Pharma: Indian specialty pharma with branded formulations in gynecology, dermatology and primary care, with a heavy emerging-markets (Africa, Asia) export orientation — directly comparable to Mercury Labs' geographic and therapeutic positioning.
• Strides Pharma Science: Indian pharma with branded and generic formulations across multiple therapeutic areas and significant emerging-markets exposure (especially Africa) — comparable international GTM and dosage-form capabilities to Mercury Labs.

Broad incumbents

• Cipla: One of India's largest pharmaceutical manufacturers with a broad portfolio spanning branded generics, APIs and complex formulations across therapeutic categories; operates globally with strong emerging-market presence, overlapping Mercury Labs' formulations and export markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mercury Laboratories